Ad is loading...
GIDAX
Price
$7.08
Change
-$0.02 (-0.28%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

GIDAX vs VTSNX

Header iconGIDAX vs VTSNX Comparison
Open Charts GIDAX vs VTSNXBanner chart's image
Goldman Sachs Intl Eq Div & Prem A
Price$7.08
Change-$0.02 (-0.28%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
GIDAX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GIDAX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIDAX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. GIDAX (148M). VTSNX pays higher dividends than GIDAX: VTSNX (3.29) vs GIDAX (3.12). GIDAX was incepted earlier than VTSNX: GIDAX (17 years) vs VTSNX (14 years). GIDAX is a more actively managed with annual turnover of: 18.00 vs. VTSNX (4.00). GIDAX has a lower initial minimum investment than VTSNX: GIDAX (1000) vs VTSNX (5000000). VTSNX annual gain was more profitable for investors over the last year : 10.92 vs. GIDAX (5.92). VTSNX return over 5 years is better than : 15.91 vs. GIDAX (11.89).
GIDAXVTSNXGIDAX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD-1.2924.535-28%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets148M442B0%
Annual Yield % from dividends3.123.2995%
Returns for 1 year5.9210.9254%
Returns for 3 years3.83-5.86-65%
Returns for 5 years11.8915.9175%
Returns for 10 years15.9229.8153%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals